Literature DB >> 1716665

Plasma exchange in the treatment of Refsum's disease (heredopathia atactica polyneuritiformis).

D Harari1, F B Gibberd, J P Dick, M C Sidey.   

Abstract

Five cases of heredopathia atactica polyneuritiformis (HAP--Refsum's disease) were treated by serial plasma exchanges. In all patients a reduction in calorie intake and body weight had been associated with a rise in plasma phytanic acid, followed by an exacerbation of the ataxia and neuropathy. Lowering the plasma phytanic acid by plasma exchange produced a rapid clinical improvement. The main indication for plasma exchange in HAP is a severe or rapidly worsening clinical condition. A lesser indication is failure of dietary management to reduce a high plasma phytanic acid level.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716665      PMCID: PMC1014432          DOI: 10.1136/jnnp.54.7.614

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  The significance of plasma phytanic acid levels in adults.

Authors:  T C Britton; F B Gibberd; M E Clemens; J D Billimoria; M C Sidey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

2.  A child with Refsum's disease: successful treatment with diet and plasma exchange.

Authors:  N Dickson; J G Mortimer; J M Faed; A C Pollard; M Styles; D A Peart
Journal:  Dev Med Child Neurol       Date:  1989-02       Impact factor: 5.449

3.  Therapeutic trial of plasmapheresis in Refsum disease and in Fabry disease.

Authors:  H W Moser; H Braine; R E Pyeritz; D Ullman; C Murray; A K Asbury
Journal:  Birth Defects Orig Artic Ser       Date:  1980

Review 4.  Plasma exchange in neurological diseases.

Authors:  P O Behan; W M Behan
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

5.  Note on plasma exchange therapy in Refsum's disease.

Authors:  P E Penovich; J Hollander; J A Nusbacher; R C Griggs; J MacPherson
Journal:  Adv Neurol       Date:  1978

6.  The formation of alpha-hydroxy phytanic acid from phytanic acid in mammalian tissues.

Authors:  S C Tsai; J H Herndon; B W Uhlendorf; H M Fales; C E Mize
Journal:  Biochem Biophys Res Commun       Date:  1967-08-23       Impact factor: 3.575

7.  Refsum's disease: management by diet and plasmapheresis.

Authors:  J P Hungerbühler; C Meier; L Rousselle; P Quadri; J Bogousslavsky
Journal:  Eur Neurol       Date:  1985       Impact factor: 1.710

8.  Plasma exchange in myasthenia gravis complicated with complement activation and urticarial reactions using fresh-frozen plasma as replacement solution.

Authors:  J Rosenkvist; A Berkowicz; E Holsøe; H Sørensen; E Taaning
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

9.  Heredopathia atactica polyneuritiformis: Refsum's disease.

Authors:  F B Gibberd; J D Billimoria; J M Goldman; M E Clemens; R Evans; M N Whitelaw; S Retsas; R M Sherratt
Journal:  Acta Neurol Scand       Date:  1985-07       Impact factor: 3.209

10.  Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange.

Authors:  F B Gibberd; J D Billimoria; N G Page; S Retsas
Journal:  Lancet       Date:  1979-03-17       Impact factor: 79.321

View more
  5 in total

Review 1.  [Therapeutic plasma exchange 1996].

Authors:  U Weber; W Riegel; H Köhler
Journal:  Med Klin (Munich)       Date:  1997-10-15

2.  Transport of phytanic acid on lipoproteins in Refsum disease.

Authors:  A S Wierzbicki; A Sankaralingam; P J Lumb; T C Hardman; M C Sidey; F B Gibberd
Journal:  J Inherit Metab Dis       Date:  1999-02       Impact factor: 4.982

3.  Hypokalaemia in acute Refsum's disease.

Authors:  J P Dick; K Meeran; F B Gibberd; F C Rose
Journal:  J R Soc Med       Date:  1993-03       Impact factor: 18.000

4.  Midlife diagnosis of Refsum disease in siblings with retinitis pigmentosa -- the footprint is the clue: a case report.

Authors:  Hari Jayaram; Susan M Downes
Journal:  J Med Case Rep       Date:  2008-03-12

Review 5.  Genetics behind Cerebral Disease with Ocular Comorbidity: Finding Parallels between the Brain and Eye Molecular Pathology.

Authors:  Kao-Jung Chang; Hsin-Yu Wu; Aliaksandr A Yarmishyn; Cheng-Yi Li; Yu-Jer Hsiao; Yi-Chun Chi; Tzu-Chen Lo; He-Jhen Dai; Yi-Chiang Yang; Ding-Hao Liu; De-Kuang Hwang; Shih-Jen Chen; Chih-Chien Hsu; Chung-Lan Kao
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.